Tags : Vischer

Capital Markets Corporate

VISCHER: BlackSheep MadTech Fund invests in Nexoya

BlackSheep MadTech Fund, managed by EUREKA! Venture SGR, the first European venture capital fund with an entrepreneurial background that invests in the marketing and advertising technology industry, has been the lead investor in the USD 5m series A investment round of Nexoya, a Swiss marketing analytics start up. The Swiss-German MadTech start-up plans to expand […]

Deal & transactions

Vischer: Huntsman sells Textile Effects Division to Archroma

Huntsman Corporation closed the sale of its Textile Effects division to Archroma,  a portfolio company of SK Capital Partners, on February 28, 2023. The agreed purchase price was $593 million in cash plus assumed pension liabilities, and Huntsman expects the net after tax cash proceeds to be approximately $540 million before customary post-closing adjustments. Huntsman […]

Corporate Deal & transactions

VISCHER: Medartis increases stake in KeriMedical

Medartis, a Basel-based orthopedic company specializing in head and extremity surgery, recently signed an agreement with the private founders of KeriMedical, a Geneva-based private company specializing in the development and manufacture of implants for hand and wrist surgery, to acquire an additional 18% stake for a purchase price of approximately CHF 18million. This increase of […]

Deal & transactions

Vischer advises Medartis on its stake expansion in KeriMedical 

Basel-based orthopedic firm, Medartis, has successfully completed the acquisition of an additional 18% stake in Geneva-based implant manufacturer, KeriMedical, for approximately CHF 18 million. This deal will raise Medartis’ stake to 47%, further cementing the company’s commitment to becoming a one-stop-shop for hand and wrist solutions, as well as increasing its presence in extremity joint […]

Corporate Pharma

Vischer advises Oculis on its public listing on Nasdaq

Oculis Holding, a global biopharmaceutical company, purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”). At closing, Oculis had a pro-forma enterprise value of approximately USD 220m and a cash balance exceeding USD 117m prior to payment of […]


Vischer advises CODE41 in its issuance of tokenised securities

CODE41, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form of ledger-based securities, thanks to the tokenisation technology of Taurus and the opensource smart contract published by CMTA. VISCHER has advised CODE41 in the process. The team was led by partner Maxime Chollet (corporate/m&a, pictured) and included […]

Capital Markets

Vischer advises Fangda on GDR Offering and Listing on SIX 

Fangda Carbon New Material Co., an integrated carbon materials producer in in the People’s Republic of China with diversified product offerings, including graphite electrodes, carbon blocks, isostatic graphite and iron ore concentrates, sold 22m global depositary receipts (GDRs) at an offer price of USD 8.63 per GDR and listed on 15 March 2023 a total […]

Corporate Pharma

Baker McKenzie and Vischer on SHS’s investment in Simulands

The German life science and medtech private equity firm SHS Capital has made a EUR 10 million investment in Simulands, a Swiss manufacturer of simulation devices for medical training of cardiovascular interventions. The investment aims to accelerate the commercialization of this early-stage company and to help it revolutionize cardiovascular education and training. Simulands plans to […]


Tobias F. Rohner new partner at VISCHER

Tobias F. Rohner has joined VISCHER as a partner on 1 February 2023 strengthening the tax team. As a partner in the Zurich office he is co-head of the tax team. With more than 20 years of experience as a tax lawyer, Rohner has excellent expertise in advising international and domestic companies, start-ups, fund and […]

Banking & Finance

VISCHER advises Oberland Capital on its agreement with Helsinn

As we have informed here, the Helsinn Group has closed a financing agreement with Oberland Capital Management. In this sense, VISCHER has advised Oberland Capital Management on its financing agreement with the Ticino based group. Oberland Capital is a private investment firm with assets under management in excess of USD 3 bn, focused exclusively on investing […]